John Hackett, Jr of Abbott Labs needs to be added to the list. He presented February 19 at CROI 2010 in San Francisco. He represented Abbott and indicated they were extremely close to having a test for XMRV. Abbott makes an analyzer used to screen blood supplies for HIV, HepB, and HepC. Since they already have the expertise for these viruses, adding XMRV wouldn't be difficult.
Look at the names involved in the study: XMRV: Examination of Viral Kinetics, Tissue Tropism, and Serological Markers of Infection
X Qiu1, P Swanson1, K-C Luk1, J Das Gupta2, N Onlamoon3, R Silverman2, F Villinger3, S Devare1, G Schochetman1, and John Hackett, Jr*1
1Abbott Diagnostics, Abbott Park, IL, US; 2Cleveland Clin, OH, US; and 3Yerkes Natl Primate Res Ctr, Emory Univ, Atlanta, GA, US
Also, John Petros, MD needs to be added:
John A. Petros, MD, associate professor of urology, Emory School of Medicine and Veterans Administration Hospital - An article published in the April 2010 issue of Urology is a step in this direction as researchers from Emory University report the successful development of an experimental clinical test for XMRV. Petros and co-investigators adapted technology developed in the HIV arena (neutralizing antibody assay) and have developed a serum test that can identify patients who have previously been infected with the virus. Two independent labs and independent technologies (PCR and FISH) confirmed the test.